These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29397262)

  • 1. Consequences of dysregulated complement regulators on red blood cells.
    Thielen AJF; Zeerleder S; Wouters D
    Blood Rev; 2018 Jul; 32(4):280-288. PubMed ID: 29397262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of Complement in Post-Transfusion Hemolysis and Hyperhemolysis Reaction.
    Roumenina LT; Bartolucci P; Pirenne F
    Transfus Med Rev; 2019 Oct; 33(4):225-230. PubMed ID: 31672341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G6PD-deficiency infectious haemolysis: a complement dependent innocent bystander phenomenon.
    Kasper ML; Miller WJ; Jacob HS
    Br J Haematol; 1986 May; 63(1):85-91. PubMed ID: 3707864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of complement-mediated immune hemolysis by a small molecule compound.
    Mqadmi A; Zheng X; Song J; Abramowitz S; Giclas P; Yazdanbakhsh K
    Biochem Biophys Res Commun; 2004 Dec; 325(4):1465-71. PubMed ID: 15555593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complement receptor 1 inhibitors for prevention of immune-mediated red cell destruction: potential use in transfusion therapy.
    Yazdanbakhsh K; Kang S; Tamasauskas D; Sung D; Scaradavou A
    Blood; 2003 Jun; 101(12):5046-52. PubMed ID: 12576307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Warm autoimmune hemolytic anemia.
    Naik R
    Hematol Oncol Clin North Am; 2015 Jun; 29(3):445-53. PubMed ID: 26043384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement inhibitors to treat IgM-mediated autoimmune hemolysis.
    Wouters D; Zeerleder S
    Haematologica; 2015 Nov; 100(11):1388-95. PubMed ID: 26521297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility of haemolysin-sensitized erythrocytes to complement-mediated cytotoxicity: a biological manifestation of the relationship between antibody availability and complement fixation.
    Bakács T; Ringwald G; Kimber I
    J Clin Lab Immunol; 1989 Oct; 30(2):61-7. PubMed ID: 2641530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The James Blundell Award Lecture 2007: do we really understand immune red cell destruction?
    Garratty G
    Transfus Med; 2008 Dec; 18(6):321-34. PubMed ID: 19140815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complement in hemolytic anemia.
    Brodsky RA
    Hematology Am Soc Hematol Educ Program; 2015; 2015():385-91. PubMed ID: 26637747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Shiga toxin-induced complement-mediated hemolysis and release of complement-coated red blood cell-derived microvesicles in hemolytic uremic syndrome.
    Arvidsson I; Ståhl AL; Hedström MM; Kristoffersson AC; Rylander C; Westman JS; Storry JR; Olsson ML; Karpman D
    J Immunol; 2015 Mar; 194(5):2309-18. PubMed ID: 25637016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of marathon running on expression of the complement regulatory proteins CD55 (DAF) and CD59 (MACIF) on red blood cells.
    Simpson RJ; Florida-James GD; Whyte GP; Middleton N; Shave R; George K; Guy K
    Eur J Appl Physiol; 2007 Jan; 99(2):201-4. PubMed ID: 17089158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Controlling the complement system for prevention of red cell destruction.
    Yazdanbakhsh K
    Curr Opin Hematol; 2005 Mar; 12(2):117-22. PubMed ID: 15725901
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of complement in immunohematology.
    Garratty G
    Crit Rev Clin Lab Sci; 1984; 20(1):25-56. PubMed ID: 6373144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extravascular hemolysis and complement consumption in Paroxysmal Nocturnal Hemoglobinuria patients undergoing eculizumab treatment.
    Subías Hidalgo M; Martin Merinero H; López A; Anter J; García SP; Ataúlfo Gonzalez-Fernández F; Forés R; Lopez-Trascasa M; Villegas A; Ojeda E; Rodríguez de Córdoba S
    Immunobiology; 2017 Feb; 222(2):363-371. PubMed ID: 27644115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discriminating complement-mediated acute transfusion reaction for type O+ red blood cells transfused into a B+ recipient with the complement hemolysis using human erythrocytes (CHUHE) assay.
    Cunnion KM; Hair PS; Krishna NK; Whitley PH; Goldberg CL; Fadeyi EA; Maes LY
    Transfusion; 2016 Jul; 56(7):1845-8. PubMed ID: 26997226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement inhibition significantly decreases red blood cell lysis in a rat model of acute intravascular hemolysis.
    Shah TA; Mauriello CT; Hair PS; Sharp JA; Kumar PS; Lattanzio FA; Werner AL; Whitley PH; Maes LA; Cunnion KM; Krishna NK
    Transfusion; 2014 Nov; 54(11):2892-900. PubMed ID: 24806146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment of a method for measuring total complement activity based on a hemolysis system using own red blood cells.
    Dong R; Liu H
    J Immunol Methods; 2016 Mar; 430():21-7. PubMed ID: 26809049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Eculizumab treatment: stochastic occurrence of C3 binding to individual PNH erythrocytes.
    Sica M; Rondelli T; Ricci P; De Angioletti M; Risitano AM; Notaro R
    J Hematol Oncol; 2017 Jun; 10(1):126. PubMed ID: 28629435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The mechanism and modulation of complement activation on polymer grafted cells.
    Leung VL; Kizhakkedathu JN
    Acta Biomater; 2016 Feb; 31():252-263. PubMed ID: 26593783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.